Peptix A-19 Lung Peptide Bioregulator with Taxorest

Your lungs do one job all day, every day, without a break. The bronchial mucosa is the tissue that lines those airways. It filters, humidifies, and helps move particles out before they reach the deeper lung. Like every other tissue in the body, it depends on healthy protein synthesis at the cellular level to maintain that function. And like every other tissue, its capacity to do that declines with age. Peptix A-19 delivers peptide complex A-19, a tissue-specific bioregulator sourced from the bronchial mucosa of young calves and pigs. Each capsule contains 10mg of peptide complex A-19. The daily dose is 2 capsules (20mg). Sixty capsules gives you a full 30-day course. The research behind it: Peptix A-19 is built on the Khavinson framework. Prof. Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology spent decades establishing that aging is driven largely by changes in gene expression that result in reduced synthesis of tissue-specific peptides. When those peptides fall, the tissues they regulate lose structural and functional integrity. Based on articles retrieved from PubMed, Khavinson described this as an evolutionary process of impaired peptide production in organs that provokes structural and functional changes over time. The correction, he proposed, comes from stimulating peptide production or delivering the peptides directly. (Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PMID: 12374906) The mechanism is epigenetic. According to PubMed, short peptides bind complementarily to specific nucleotide sequences in DNA strands. That binding reduces the strength of proton bonds in the DNA double helix and stimulates gene transcription and replication. This is the process by which tissue-specific protein synthesis is initiated and maintained. (Khavinson VKh et al. Epigenetic aspects of peptide regulation of aging. Adv Gerontol. 2012;25(1):11-22. PMID: 22708439) That mechanism matters for bronchial tissue specifically. Based on articles retrieved from PubMed, research on alveolar type II cells confirms that impaired DNA damage repair and mitochondrial dysfunction in lung epithelial cells contributes directly to declining lung tissue integrity with age. Maintaining cellular repair capacity in bronchial tissue is a key variable in supporting normal respiratory function over time. (Simborio et al. Mitochondrial dysfunction and impaired DNA damage repair in alveolar type II cells. Cell Commun Signal. 2024;22(1):562. DOI: 10.1186/s12964-024-01896-0) Peptix A-19 targets that cellular layer directly. It may help support normal protein synthesis in bronchial mucosa tissue as part of a long-term peptide bioregulator protocol. What is in each capsule: Peptide complex A-19 (extract from bronchial mucosa of calves under 12 months or pigs), microcrystalline cellulose (E460), beet sugar, sugar, lactose, starch. Suggested use: Take 1 to 2 capsules with meals, 1 to 2 times per day for 30 days. Repeat every 3 to 6 months. Who orders Peptix A-19: People who want to support normal bronchial tissue function as part of a structured peptide bioregulator protocol. This is not a daily supplement you take forever. It is a 30-day course you repeat twice a year. Peptix A-19 is the lung piece of the Respiratory System Bundle. It pairs with Vladonix (A-6, thymus) and Ventfort (A-3, blood vessels) to cover the full respiratory system in the Khavinson protocol. The thymus supports immune function. The blood vessels support circulation. The bronchial mucosa handles the airway tissue itself. Three organs. One course. Run them together. Available as 20 capsules (10-day starter course) or 60 capsules (full 30-day course). Cross-sell stack: Vladonix A-6 Thymus Peptide Bioregulator | Ventfort A-3 Blood Vessel Bioregulator | Respiratory System Peptide Bundle These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.